| Praveena R Kothur, MD | |
|
4901 N 44th St Ste 103, Phoenix, AZ 85018-2782 | |
| (602) 954-0405 | |
| (602) 954-0485 |
| Full Name | Praveena R Kothur |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 35 Years |
| Location | 4901 N 44th St Ste 103, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114973179 | NPI | - | NPPES |
| 792053 | Medicaid | AZ | |
| Z302567 | Other | AZ | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 30666 (Arizona) | Primary |
| Entity Name | Valley Allergy And Asthma Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760429641 PECOS PAC ID: 8123004660 Enrollment ID: O20040625000859 |
News Archive
The German Institute for Quality and Efficiency in Health Care investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with the appropriate comparator therapies for patients with melanoma.
Studying the genetic code allows researchers to know whether some patients with neuropsychiatric disorders either have extra copies of the CHRNA7 gene or are missing copies. However, little was known about the functional consequences of this genetic imbalance in brain cells.
Though the initial phase of the debt deal doesn't include immediate provider cuts, analysts say the next phase — the work of the 'super committee' — could make significant reductions in spending for entitlements like Medicare and Medicaid. Even some elements of the health law and scientific research could be on the chopping block.
A study of more than 400 children of first-generation immigrants is among the first longitudinal studies to demonstrate that one's ethnic identity forms prior to adolescence.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that extends the current patent coverage for the Company's MultiStat family of compounds. The forthcoming patent is part of a portfolio that Quick-Med has licensed from the University of Michigan.
› Verified 1 days ago
| Entity Name | Allergy Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841235025 PECOS PAC ID: 7113822420 Enrollment ID: O20060811000062 |
News Archive
The German Institute for Quality and Efficiency in Health Care investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with the appropriate comparator therapies for patients with melanoma.
Studying the genetic code allows researchers to know whether some patients with neuropsychiatric disorders either have extra copies of the CHRNA7 gene or are missing copies. However, little was known about the functional consequences of this genetic imbalance in brain cells.
Though the initial phase of the debt deal doesn't include immediate provider cuts, analysts say the next phase — the work of the 'super committee' — could make significant reductions in spending for entitlements like Medicare and Medicaid. Even some elements of the health law and scientific research could be on the chopping block.
A study of more than 400 children of first-generation immigrants is among the first longitudinal studies to demonstrate that one's ethnic identity forms prior to adolescence.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that extends the current patent coverage for the Company's MultiStat family of compounds. The forthcoming patent is part of a portfolio that Quick-Med has licensed from the University of Michigan.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Praveena R Kothur, MD Po Box 603725, Charlotte, NC 28260-3725 Ph: (828) 575-2625 | Praveena R Kothur, MD 4901 N 44th St Ste 103, Phoenix, AZ 85018-2782 Ph: (602) 954-0405 |
News Archive
The German Institute for Quality and Efficiency in Health Care investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with the appropriate comparator therapies for patients with melanoma.
Studying the genetic code allows researchers to know whether some patients with neuropsychiatric disorders either have extra copies of the CHRNA7 gene or are missing copies. However, little was known about the functional consequences of this genetic imbalance in brain cells.
Though the initial phase of the debt deal doesn't include immediate provider cuts, analysts say the next phase — the work of the 'super committee' — could make significant reductions in spending for entitlements like Medicare and Medicaid. Even some elements of the health law and scientific research could be on the chopping block.
A study of more than 400 children of first-generation immigrants is among the first longitudinal studies to demonstrate that one's ethnic identity forms prior to adolescence.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that extends the current patent coverage for the Company's MultiStat family of compounds. The forthcoming patent is part of a portfolio that Quick-Med has licensed from the University of Michigan.
› Verified 1 days ago
Fadia K Habib-khazen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4901 N 44th St Ste 103, Phoenix, AZ 85018 Phone: 602-954-0405 Fax: 602-954-0485 | |
Mark Samuel Schubert, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 W Clarendon Ave, Ste 120, Phoenix, AZ 85013 Phone: 602-277-3337 Fax: 602-277-3330 | |
Dr. Christopher E. Couch, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 300 W Clarendon Ave, Suite 120, Phoenix, AZ 85013 Phone: 602-277-3337 Fax: 602-277-3330 | |
Dr. Allan M Wachter, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 12020 S Warner Elliot Loop, Suite 124, Phoenix, AZ 85044 Phone: 480-785-8000 Fax: 480-705-8129 | |
Dr. Stephen N Finberg, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6970 E Chauncey Ln Ste 100, Phoenix, AZ 85054 Phone: 602-788-7211 Fax: 602-788-1890 | |
Thomas Mirzai, D.O. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3815 E Bell Rd, 4400, Phoenix, AZ 85032 Phone: 602-788-7211 Fax: 602-788-1890 |